NCDActive
Vabra Aspirator
NCD173
Effective: January 1, 1966
Updated: December 31, 2025
Policy Summary
The Vabra aspirator is covered to obtain uterine/endometrial tissue for evaluation of suspected endometrial disease in patients with clinical signs or symptoms (for example, irregular or heavy vaginal bleeding). Payment is not allowed when the device or related diagnostics are used for asymptomatic patients or routine physical exams per §1862(a)(7). The policy does not specify frequency limits or detailed claim forms/prior authorization requirements.
Coverage Criteria Preview
Key requirements from the full policy
"Covered when the Vabra aspirator is used to collect uterine tissue for study to detect endometrial carcinoma in patients who exhibit clinical symptoms or signs suggestive of endometrial disease (e."
Sign up to see full coverage criteria, indications, and limitations.